Log in to your Inderes Free account to see all free content on this page.
Lumito
4.39 SEK
-5.49 %
Less than 1K followers
LUMITO
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Lumito
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | ||||||
| growth-% | |||||||
| EBITDA | -7.9 | -16.1 | -26.3 | -27.2 | -26.4 | -26.2 | -22.4 |
| EBIT | -7.9 | -16.1 | -26.4 | -27.3 | -26.5 | -38.3 | -41.9 |
| Profit before taxes | -7.9 | -16.0 | -26.4 | -27.0 | -25.8 | -41.6 | -43.9 |
| Net income | -7.9 | -16.0 | -26.4 | -27.0 | -25.8 | -41.6 | -43.9 |
| EPS | -27.58 | -33.09 | -47.88 | -29.43 | -5.52 | -33.11 | -45.00 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Login required
This content is only available for logged in users
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -26,160.0 % | ||||||
| EBIT-% | -38,300.0 % | ||||||
| ROE | -12.7 % | -17.1 % | -23.4 % | -20.8 % | -25.0 % | -44.8 % | -58.0 % |
| ROI | -11.6 % | -16.3 % | -21.8 % | -19.8 % | -21.2 % | -37.1 % | -50.0 % |
Login required
This content is only available for logged in users